In one of the largest all-private licensing deals so far this year, worth around 500 million euros ($569 million), ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) late Friday announced it has granted a conditional ...

Opening the door to wider treatment access and faster adoption of oral therapies for obstructive sleep apnea (OSA) and other ...

US healthcare giant Johnson & Johnson (NYSE: JNJ) has shared new findings for TAR-200, an intravesical gemcitabine releasing ...

Seeking to ensure the quality and safety of pharmaceutical products, India's regulatory bodies have intensified their ...

US pharma major Pfizer (NYSE: PFE) reported new Phase III data over the weekend showing that its investigational PD-1 ...

Among research news last week, Gilead Sciences released positive new Phase III data on progression fee survival for its Trodelvy plus Keytruda in breast cancer. Roivant company Immunovant last week ...

The European Medicines Agency’s (EMA)) human medicines committee (CHMP) has recommended seven novel medicines for approval at ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Beyonttra (acoramidis), from Germany’s Bayer ...

Chinese biotech LTZ Therapeutics has closed an oversubscribed series A+ financing round, raising $40 million to support its ...

Precision oncology company Guardant Health has announced a strategic collaboration with Pfizer to support the development and ...

UK-listed medtech Convatec Group (LSE: CTEC) plans to launch its new wound care technology, ConvaNiox (nitric oxide), later ...